Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05599425
Other study ID # R21AG075328
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2023
Est. completion date April 30, 2024

Study information

Verified date October 2022
Source Rhode Island Hospital
Contact Laura Korthauer, PhD
Phone 4014444500
Email laura_korthauer@brown.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Modifying health behaviors like physical activity level, diet, stress, and mental activity level can lower risk for Alzheimer's disease, but many middle-aged and older adults find it difficult to sustain health behavior changes over the long term. This project will develop a new intervention that educates people about Alzheimer's disease risk factors and helps them understand how their personal health beliefs may prevent them from making long-lasting lifestyle changes. The goal is to help people sustain health behavior changes to prevent or delay the onset of Alzheimer's disease and related dementias.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date April 30, 2024
Est. primary completion date April 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 69 Years
Eligibility Inclusion Criteria: - age 45-69 years - normal cognition (Minnesota Cognitive Acuity Scale > 52) - English language fluency - at least two of the following: i) BMI > 24.9; ii) systolic blood pressure > 125 mmHg; iii) LDL cholesterol > 115 mg/dL; iv) HbA1C > 6.0%; v) at least one APOE e4 allele; vi) first-degree relative with AD. Exclusion Criteria: - history of serious mental illness (i.e., schizophrenia, bipolar disorder) - history of neurologic or neurodevelopmental disorder - current alcohol or drug use disorder based on self-report - current enrollment in an AD prevention clinical trial.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Enhanced Healthy Living Education
24-session healthy living education program, with enhanced content about health beliefs and mechanisms of behavior change
Basic Healthy Living Education
24-session healthy living education program

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Rhode Island Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Perceived Threat of Alzheimer's Disease Scale 7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat baseline
Primary Perceived Threat of Alzheimer's Disease Scale 7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat 4 weeks
Primary Perceived Threat of Alzheimer's Disease Scale 7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat 8 weeks
Primary Perceived Threat of Alzheimer's Disease Scale 7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat 12 weeks (treatment endpoint)
Primary Dementia Awareness Questionnaire self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness baseline
Primary Dementia Awareness Questionnaire self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness 4 weeks
Primary Dementia Awareness Questionnaire self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness 8 weeks
Primary Dementia Awareness Questionnaire self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness 12 weeks
Primary Generalized Self-Efficacy Scale 10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy baseline
Primary Generalized Self-Efficacy Scale 10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy 4 weeks
Primary Generalized Self-Efficacy Scale 10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy 8 weeks
Primary Generalized Self-Efficacy Scale 10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy 12 weeks
Secondary Mediterranean Diet Assessment Tool 14-item measure of adherence to a Mediterranean type diet; higher scores indicate greater diet adherence baseline
Secondary Mediterranean Diet Assessment Tool 14-item measure of adherence to a Mediterranean type diet; higher scores indicate greater diet adherence 12 weeks
Secondary CHAMPS Activities Questionnaire for Older Adults self-report measure of engagement in physical activities, tailored to older adult population; higher scores indicate greater engagement in physical activity baseline
Secondary CHAMPS Activities Questionnaire for Older Adults self-report measure of engagement in physical activities, tailored to older adult population; higher scores indicate greater engagement in physical activity 12 weeks
Secondary Florida Cognitive Activities Scale 25-item self-report measure about engagement in mentally stimulating activities; higher scores indicate greater cognitive activity baseline
Secondary Florida Cognitive Activities Scale 25-item self-report measure about engagement in mentally stimulating activities; higher scores indicate greater cognitive activity 12 weeks
Secondary Perceived Stress Scale 10-item measure that assesses perceived stress; higher scores indicate greater perceived stress baseline
Secondary Perceived Stress Scale 10-item measure that assesses perceived stress; higher scores indicate greater perceived stress 4 weeks
Secondary Perceived Stress Scale 10-item measure that assesses perceived stress; higher scores indicate greater perceived stress 8 weeks
Secondary Perceived Stress Scale 10-item measure that assesses perceived stress; higher scores indicate greater perceived stress 12 weeks
Secondary Positive and Negative Affect Schedule 20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively baseline
Secondary Positive and Negative Affect Schedule 20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively 4 weeks
Secondary Positive and Negative Affect Schedule 20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively 8 weeks
Secondary Positive and Negative Affect Schedule 20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A